🔎 Trials Near Me

Home › Oropharyngeal Cancer › Missouri › St. Louis

Oropharyngeal Cancer clinical trials in St. Louis, MO

5 studies for Oropharyngeal Cancer are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

RecruitingPhase 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • and 2 more
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07195734

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

RecruitingPhase 2
  • Washington University School of Medicine, St Louis
  • Mercy Hospital South, St Louis
  • Siteman Cancer Center-South County, St Louis
  • and 4 more
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05136196

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

RecruitingPhase 3
  • Cancer Care Center of O'Fallon, O'Fallon · 16 mi away
  • HSHS Saint Elizabeth's Hospital, O'Fallon · 16 mi away
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT07441681

The Minimalist Trial-2

RecruitingPhase 2
  • Washington University School of Medicine, St Louis
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT06702033

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

Recruiting
  • Washington University in St. Louis, St Louis
Ages 18 and older · All sexes · Updated Dec 11, 2025 · NCT05793151

Oropharyngeal Cancer trials in other cities

Other studies in St. Louis

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.